Biotech investor, company builder

João merges a wealth of scientific expertise with business acumen and entrepreneurial spirit. He is currently a Senior Associate at Novo Holdings, the Chief Business Officer at Orbis Medicines, and holds a series of board positions. In his current role, João led the investments in Tribune Therapeutics, Asgard Therapeutics, and Orbis Medicines.

Prior to joining Novo Holdings, João worked at M Ventures, the corporate venture arm of Merck KGaA, participating in transactions of Plexium and Pantheon Biosciences. He was a Fellow at the European Institute of Innovation and Technology and a member of MIT Hacking Medicine. While in the US, João was also the President of a non-profit organization.

He holds a Ph.D. in Bioengineering from the University of Coimbra and performed his doctoral thesis at Harvard Medical School & Brigham and Women's Hospital in Boston. He holds several entrepreneurial awards.

João is a surfer, adventurer, and lover of the arts. He frequently paints and likes to explore the intersection between science and art.

João Ribas

"I am passionate about empowering entrepreneurs and startups to succeed."

João Ribas // 2022